Cubist Systematic Strategies’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Cubist Systematic Strategies’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-441,052	Closed	-$4.53M	–	4709
2022 Q4	$4.53M	Sell	441,052 -13,107	-3%	-$133K	0.03%	1104
2022 Q3	$4.57M	Buy	454,159 +14,629	+3%	+$147K	0.03%	1159
2022 Q2	$4.4M	Buy	439,530 +12,288	+3%	+$123K	0.03%	1103
2022 Q1	$4.27M	Buy	+427,242	New	+$4.24M	0.04%	850

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Cubist Systematic Strategies's IQMD Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 441,052 shares — an estimated $4.53M sold.

Cubist Systematic Strategies first reported a position in IQMD in Q1 2022 and held it in 4 quarters. The position peaked at $4.57M in Q3 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Cubist Systematic Strategies reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 441,052 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $4.53M.
Cubist Systematic Strategies first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 4 quarters.
Cubist Systematic Strategies's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $4.57M in Q3 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.